Summary of Significant Accounting Policies |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Accounting Policies [Abstract] | |
| Summary of Significant Accounting Policies |
Note 3 – Summary of Significant Accounting Policies
Basis of presentation and principles of consolidation
The accompanying condensed consolidated financial statements, as of September 30, 2026 and for the three and nine months ended September 30, 2026, are unaudited and have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial statements. The condensed consolidated balance sheet as of December 31, 2025 was derived from audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures are adequate to make the information presented not misleading.
In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the Company’s financial position as of September 30, 2026, and its results of operations, changes in stockholders’ equity and cash flows for the interim periods presented. All such adjustments are of a normal recurring nature. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the full fiscal year or any future period.
The accompanying unaudited condensed consolidated financial statements include the consolidated accounts of the Company and its wholly owned subsidiaries, BioPharma, and Nanotechnologies and reflect the operations of the Company and its wholly owned subsidiaries. All intercompany transactions have been eliminated in consolidation. There have been no material changes to the Company’s significant accounting policies described in Note 3 within the Company’s Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
The Company’s management has considered all recent accounting pronouncements issued and believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
Reverse Stock Split
On September 28, 2026, the Company effected a 1-for-15 reverse stock split of its issued and outstanding common stock (the “2026 Reverse Stock Split”). The Company’s common stock began trading on a split adjusted basis on September 28, 2026. No fractional shares were issued as a result of the 2026 Reverse Stock Split as stockholders otherwise entitled to a fractional share of common stock received a proportional cash payment.
Unless otherwise noted in these condensed consolidated financial statements, all shares of common stock, warrants convertible into shares of common stock, stock options, per share information, and related parameters specified in this quarterly report have been retroactively adjusted to reflect the 2026 Reverse Stock Split for all periods presented. Refer to Note 9 – Stockholders’ Equity for additional information related to the 2026 Reverse Stock Split.
Segment and geographic information
Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the Chief Operating Decision Maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. The Company considers its chief executive officer to be the Company’s CODM. The CODM manages its operations and allocates resources based on the Company’s consolidated results and therefore operates as one segment.
The accounting policies of the Company’s single operating and reportable segment are the same as those described in this Summary of Significant Accounting Policies. The Company’s method for measuring segment profitability includes net income (loss), which the CODM uses to assess performance and make decisions for resource allocation, consistent with the measurement principles for net income (loss) as reported on the Company’s condensed consolidated statement of operations. The significant assets and expenses regularly reviewed by the CODM are consistent with those reported on the Company’s condensed consolidated balance sheet and condensed consolidated statement of operations. The measure of segment assets is reported in the condensed consolidated balance sheet as total assets. Segment revenues and expenses are identical to that disclosed in the accompanying condensed consolidated statement of operations.
|